AI Summary
✦ ClarthaCaprolactam Chemicals Limited is an Indian chemicals manufacturer that also provides job work services. Chemicals manufacturing drives core revenue, while job work contributes service income; product-level revenue splits are unavailable. No major recent developments offer a clear catalyst for volume growth or margin expansion. Stable margins and a 30.9% ROE indicate efficient reported profitability, though 140.22x debt-to-equity implies extreme leverage and materially magnifies ROE risk. At 12.5x earnings, the stock appears discounted versus typical specialty-chemical valuations, but the discount reflects financing risk and limited operating disclosure. The neutral outlook is appropriate until deleveraging or clearer product economics emerge.
Valuation Metrics
Trading 7.9% below historical median. Valuation is stable — currently in the strongly undervalued zone (z-score: -0.59). Confidence: 84%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
14.14
Current
12.48
Overvalued
15.17
Undervalued
12.07
5Y Average
7.91
Current
6.99
Overvalued
8.78
Undervalued
6.81
5Y Average
4.16
Current
3.34
Overvalued
4.79
Undervalued
3.54
Peers & Comparison
No sector data available for this company.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹3.07 CrMar 2026Latest net profit
₹0.84 CrMar 2026Latest EPS
₹1.83Mar 2026Net margin
53.8%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2.22 | 2.06 | 1.97 | 1.49 | 1.44 | 1.12 | 1.71 | 2.29 | 1.61 | 2.56 | 2.36 | 2.56 | 3.07 |
| Expenses + | 1.51 | 1.30 | 1.52 | 1.20 | 0.77 | 0.87 | 1.14 | 1.82 | 1.38 | 1.51 | 1.70 | 1.45 | 1.42 |
| Operating Profit | 0.71 | 0.76 | 0.45 | 0.29 | 0.67 | 0.25 | 0.57 | 0.47 | 0.23 | 1.05 | 0.66 | 1.11 | 1.65 |
| OPM % | 31.98% | 36.89% | 22.84% | 19.46% | 46.53% | 22.32% | 33.33% | 20.52% | 14.29% | 41.02% | 27.97% | 43.36% | 53.75% |
| Other Income + | -0.01 | 0.15 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.00 | 0.01 |
| Interest | 0.15 | 0.14 | 0.13 | 0.11 | 0.12 | 0.14 | 0.14 | 0.17 | 0.18 | 0.18 | 0.19 | 0.18 | 0.17 |
| Depreciation | 0.39 | 0.37 | 0.39 | 0.40 | 0.42 | 0.38 | 0.40 | 0.40 | 0.41 | 0.38 | 0.39 | 0.41 | 0.44 |
| Profit before tax | 0.16 | 0.40 | -0.07 | -0.22 | 0.16 | -0.27 | 0.03 | -0.09 | -0.36 | 0.49 | 0.10 | 0.52 | 1.05 |
| Tax % | 0.00% | 25.00% | -28.57% | -31.82% | 31.25% | 0.00% | 0.00% | -66.67% | 25.00% | 24.49% | -20.00% | 17.31% | 20.00% |
| Net Profit + | 0.17 | 0.30 | -0.06 | -0.16 | 0.12 | -0.27 | 0.04 | -0.03 | -0.45 | 0.36 | 0.13 | 0.44 | 0.84 |
| EPS in Rs | 0.37 | 0.65 | -0.13 | -0.35 | 0.26 | -0.59 | 0.09 | -0.07 | -0.98 | 0.78 | 0.28 | 0.96 | 1.83 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Prior Intimation Of Board Meeting For Unaudited Financial Results For The Quarter Ended June 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018